AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $326,700 | -86.5% | 13,200 | -84.6% | 0.00% | -97.8% |
Q3 2022 | $2,422,000 | +19.3% | 85,629 | +101.5% | 0.05% | -65.2% |
Q4 2019 | $2,030,000 | -40.3% | 42,500 | -59.5% | 0.13% | -34.7% |
Q3 2019 | $3,399,000 | +24.8% | 104,900 | +92.1% | 0.20% | -32.4% |
Q2 2019 | $2,723,000 | +107.5% | 54,600 | +180.7% | 0.30% | +38.4% |
Q1 2019 | $1,312,000 | – | 19,454 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |